A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer

Liang Sun; Jiaju Lu; Zhihong Niu; Kejia Ding; Dongbin Bi; Shuai Liu; Jiamei Li; Fei Wu; Hui Zhang; Zuohui Zhao; Sentai Ding

doi:10.1371/journal.pone.0144484

Loading metrics

Open Access

Peer-reviewed

Research Article

A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer

Liang Sun,

Affiliations Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, ShanDong, China, Department of Cardiac Surgery, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, ShanDong, China
⨯
Jiaju Lu,

Affiliation Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, ShanDong, China
⨯
Zhihong Niu,

Affiliation Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, ShanDong, China
⨯
Kejia Ding,

Affiliation Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, ShanDong, China
⨯
Dongbin Bi,

Affiliation Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, ShanDong, China
⨯
Shuai Liu,

Affiliation Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, ShanDong, China
⨯
Jiamei Li,

Affiliation Department of pathology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, ShanDong, China
⨯
Fei Wu,

Affiliation Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, ShanDong, China
⨯
Hui Zhang,

Affiliation Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, ShanDong, China
⨯
Zuohui Zhao,

Affiliation Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, ShanDong, China
⨯
Sentai Ding

* E-mail: dingsentai@126.com

Affiliation Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, ShanDong, China
⨯

A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer

Liang Sun,
Jiaju Lu,
Zhihong Niu,
Kejia Ding,
Dongbin Bi,
Shuai Liu,
Jiamei Li,
Fei Wu,
Hui Zhang,
Zuohui Zhao

Published: December 10, 2015
https://doi.org/10.1371/journal.pone.0144484

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Bladder cancer
Is the Subject Area "Bladder cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Prostate cancer
Is the Subject Area "Prostate cancer" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Microarrays
Is the Subject Area "Microarrays" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Cytoplasmic staining
Is the Subject Area "Cytoplasmic staining" applicable to this article?

Thanks for your feedback.